VELLUM BIOTECHNOLOGY, INC.
Developing a New Nucleic Acid Extraction Technology to Enable High Quality DNA Sequencing for Formalin Fixed Paraffin Embedded Tissue Samples
Developing a New Nucleic Acid Extraction Technology to Enable High Quality DNA Sequencing for Formalin Fixed Paraffin Embedded Tissue Samples is a funding opportunity from VELLUM BIOTECHNOLOGY, INC., up to 1014715, closing May 31, 2027.
May 31, 2027
(304d left)Overview
Patient tissue has been collected and preserved as formalin fixed paraffin embedded tissue (FFPET) samples for over 100 years and provides a way to reliably store samples for decades. To the present day, the collection of FFPET remains a mainstay technique to support both diagnostic and research applications. As a…